Get a Gravatar from gravatar.com

United Future
Since: Aug 2007
Posts: 314

Feed for this Topic

Dunne: Health Ministry to recall Kronic brand

Associate Health Minister Peter Dunne today announced that the Ministry of Health is recalling one of the most popular brands of the synthetic cannabis product Kronic because contains the prescription medicine phenazepam. Mr Dunne said finding phenazepam – an anti-anxiety and anti-convulsion drug – in the Kronic product, Pineapple Express, again confirms the dangers of suppliers putting unregulated drugs on the market where their safety is unproven.
 “This clearly shows the worth of the Government’s moves to change the onus of proof so producers and suppliers of these products need to prove they are safe before they can sell them,” he said.
 Currently authorities have to prove such products are unsafe before they can be taken off the market.
”This particular product, because it contains a prescription medicine, is now illegal to buy, sell, use or possess without a doctor’s prescription,” he said.  Mr Dunne said this restriction applies to sellers – the retailer, wholesaler and distributors – and any member of the public who buys the product. The Health Ministry is contacting Lightyears Ahead, the company that supplies the product, to officially inform it that is required to recall Pineapple Express from retailers immediately... Read the full text of this article.

Get a Gravatar from gravatar.com

Doug Stevens
Since: Apr 2011
Posts: 6

Well done UnitedFuture. This is really sensible legislation and great to see the proposal that manufacturers and distributors must prove such drugs are OK before promoting them to the public rather than the other way round. A good rational way of dealing with what could easily become a cat and mouse situation where anyone could release products, make a big profit while legislators spent the time and the money ensuring they are either safe or not. If they are safe as the distributors claim, let them spend the time and money proving it.

Please login to post a reply. Go to Login page »